What kind of drug is bexarotene? Exploring the Rexinoid Medication for CTCL
•
4 min read
First approved by the FDA in 1999 for the treatment of cutaneous T-cell lymphoma (CTCL), the medication known as **bexarotene** is a member of the retinoid drug family. However, it is a distinct subclass of retinoids, often called rexinoids, because it selectively targets retinoid X receptors (RXRs) rather than retinoic acid receptors (RARs).
